Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Medical Management of Kidney Stones (2019)
Using AUA Guidelines
This AUA guideline is provided free of charge to the general public for clinical, academic, research and educational use purposes only. Any person or company accessing or using AUA guidelines for promotional or commercial purposes must request a license for use. To request a license for this guideline, please contact Keith Price at kprice@AUAnet.org.
To cite this guideline:
Pearle MS, Goldfarb DS, Assimos DG et al: Medical management of kidney stones: AUA Guideline. J Urol 2014; 192: 316.
Published 2014; Reviewed and Validity Confirmed 2019
The purpose of the clinical guideline on Medical Management of Kidney Stones is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Topics covered include evaluation, diet therapy, pharmacologic therapy, and follow-up.
Guideline as it appears in The Journal of Urology® [pdf]
Unabridged version of this Guideline [pdf]
Español translated guideline courtesy of Confederacion Americana de Urologia (CAU) [pdf]
Panel Members
Margaret Sue Pearle, MD, PhD.; David S. Goldfarb, MD; Dean G. Assimos, MD; Gary Curhan, MD; Cynthia J Denu-Ciocca, MD; Brian R. Matlaga, MD; Manoj Monga, MD; Kristina Lea Penniston, PhD Glenn M. Preminger, MD; Thomas M.T. Turk, MD; James Robert White, PhD